NFKB1 and polycystic ovary syndrome: In polycystic ovary syndrome (PCOS) patients, follicular fluid EVs are enriched in S100-A9, which promotes inflammation and disrupts steroidogenesis by activating the NF-κB pathway, thereby impairing granulosa cell function (Li et al., 2020).